APP and Alzheimer disease: In particular, transgenic AD mice were found to display gut dysbiosis, intestinal Aβ and amyloid protein precursor (APP) accumulation, activation of intestinal inflammatory pathways, neuronal loss and enteric glial activation in the early stages of AD [10,11].